4120-64-3

Basic information

• Product Name: 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE
• Synonyms: 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE;(5E)-2-mercapto-5-(4-nitrobenzylidene)-1,3-thiazol-4(5H)-one;(5E)-2-mercapto-5-(4-nitrobenzylidene)-1,3-thiazol-4(5H)-one(SALTDATA: FREE);(5E)-5-(4-nitrobenzylidene)-2-thioxo-thiazolidin-4-one;(5E)-5-[(4-nitrophenyl)methylene]-2-thioxo-4-thiazolidinone;(5E)-5-[(4-nitrophenyl)methylene]-2-thioxo-thiazolidin-4-one;(5E)-5-[(4-nitrophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one;5-[(4-Nitrophenyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
• CAS NO: 4120-64-3
• Molecular Formula: C₁₀H₆N₂O₃S₂
• Molecular Weight: 266.29624
• Mol File: 4120-64-3.mol
• Article Data: 35

Chemical Properties

• Melting Point: 259 °C(Solv: acetone (67-64-1))
• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.6g/cm³
• Vapor Pressure: 3.57E-07mmHg at 25°C
• Refractive Index: 1.752
• PKA: 6.98±0.30(Predicted)
• CAS DataBase Reference: 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE(4120-64-3)
• EPA Substance Registry System: 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE(4120-64-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 4120-64-3(Hazardous Substances Data)

Usage

General Description

5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE is a complex chemical compound with potential usage in various scientific and industrial applications. 5-[1-(4-NITRO-PHENYL)-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE belongs to the class of organic compounds known as nitrobenzenes, characterized by a benzene ring bearing a nitro group. The specific structure of this compound incorporates a thiazolidine backbone, further modified with a nitrophenyl group and a carbonyl (thioxo) functional group. The exact properties and potential uses of this chemical may depend on its physical characteristics or its reactivity towards other chemicals; however, these specifics are usually not readily available due to its complex nature and potential involvement in specialized research.

InChI:InChI=1/C10H6N2O3S2/c13-9-8(17-10(16)11-9)5-6-1-3-7(4-2-6)12(14)15/h1-5H,(H,11,13,16)/b8-5+

Upstream product

• 555-16-8 4-nitrobenzaldehdye 
• 19374-88-0 5-(1-methyl-3-oxo-butylidene)-2-thioxo-thiazolidin-4-one 
• 141-84-4 2-thioxo-4-thiazolidinone 
• 2700-23-4 4-Nitrobenzylidenemalononitrile 
• 28989-47-1 5-(1-methylethylidene)-2-thioxo-1,3-thiazolidin-4-one 

Downstream Products

• 28996-52-3 2-methylsulfanyl-5-(4-nitro-benzylidene)-thiazol-4-one 
• 28996-47-6 3-methyl-5-(4-nitro-benzylidene)-2-thioxo-thiazolidin-4-one 
• 32723-63-0 2-ethylsulfanyl-5-(4-nitro-benzylidene)-thiazol-4-one 
• 26438-67-5 (Z)-2-Mercapto-3-(4-nitro-phenyl)-acrylic acid 
• 32723-30-1 5-(4-nitro-benzylidene)-thiazolidine-2,4-dithione 
• 65562-19-8 5-(4-nitro-benzylidene)-3-(tetra-O-acetyl-β-D-glucopyranosyl)-2-thioxo-thiazolidin-4-one 

Relevant articles and documents

Pharmacological characterization of the cardiovascular effect of Nibethione: ex vivo, in vivo and in silico studies

Objective: This work describes the vasorelaxant and antihypertensive effects and the mechanism of action on vascular smooth muscle cells of Nibethione, a synthetic thiazolidinedione derivative. Additionally, evidence of its cytotoxicity is assessed. Methods: Nibethione (NB) was synthesized, and its vasorelaxant effect and mechanism of action were assessed through ex vivo experiments. Molecular docking studies were used to predict the mode of interaction with L-type Ca2+ channel, and in vivo antihypertensive activity was assayed on spontaneously hypertensive rats (SHR). The cytotoxicity potential was evaluated in porcine aortic endothelial cells (PAECs) from primary explants. Key findings: Nibethione vasorelaxant effect was efficient on KCl (80?mm) and NE-contraction. This effect was deleteriously modified in the presence of potassium channel block drugs, while the maximal contraction induced with NE was significantly decreased by NB; the CaCl2-induced contraction was abolished entirely. In vivo experiments showed that NB decreased diastolic blood pressure in 20.3 percent after its administration on SHR. The molecular docking showed that NB blocks L-type Ca2+ channel, and in vitro tests showed that NB did not produce cytotoxic activity on PAECs (IC50 >1000?μm). Conclusions: Nibethione showed in vivo antihypertensive and ex vivo vasorelaxant effects with implication of voltage-dependent L-type Ca2+ channel blocking, and this may contribute to the research of novel antihypertensive drugs.

Facile synthesis of 5-arylidene rhodanine derivatives using Na2SO3 as an eco-friendly catalyst. Access to 2-mercapto-3-aryl-acrylic acids and a benzoxaborole derivative

A simple, efficient and environment-friendly procedure for the synthesis of 5-arylidene rhodanines derivatives via a Knoevenagel type reaction was developed using rhodanine, a variety of differently substituted aldehydes and Na2SO3 a

Green synthesis, biological activity evaluation, and molecular docking studies of aryl alkylidene 2, 4-thiazolidinedione and rhodanine derivatives as antimicrobial agents

Aims and Objective: The magic scaffolds rhodanine and thiazolidine are very important heterocyclic compounds in drug design and discovery. Those are important heterocyclic compounds that have attracted a great deal of attention due to the fact that they e